ORTOLAN, AUGUSTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.839
AS - Asia 1.445
EU - Europa 1.149
SA - Sud America 339
AF - Africa 268
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 21
AN - Antartide 1
Totale 7.093
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.660
SG - Singapore 509
IT - Italia 301
HK - Hong Kong 281
CN - Cina 264
BR - Brasile 222
DE - Germania 160
FR - Francia 66
PL - Polonia 66
FI - Finlandia 61
SE - Svezia 59
GB - Regno Unito 57
RU - Federazione Russa 47
NL - Olanda 46
VN - Vietnam 42
IN - India 39
CA - Canada 26
IE - Irlanda 26
MX - Messico 26
AT - Austria 23
AR - Argentina 22
TR - Turchia 20
ZA - Sudafrica 20
ES - Italia 19
AU - Australia 17
IQ - Iraq 16
RO - Romania 16
TW - Taiwan 16
CO - Colombia 15
EC - Ecuador 15
AE - Emirati Arabi Uniti 14
JP - Giappone 14
VE - Venezuela 14
CW - ???statistics.table.value.countryCode.CW??? 13
JM - Giamaica 13
UA - Ucraina 13
BA - Bosnia-Erzegovina 12
EE - Estonia 12
ID - Indonesia 12
IR - Iran 12
MA - Marocco 12
AL - Albania 11
CR - Costa Rica 11
IL - Israele 11
JO - Giordania 11
PS - Palestinian Territory 11
PY - Paraguay 11
SA - Arabia Saudita 11
AZ - Azerbaigian 10
BY - Bielorussia 10
CL - Cile 10
CY - Cipro 10
GM - Gambi 10
GT - Guatemala 10
MK - Macedonia 10
NP - Nepal 10
PE - Perù 10
PT - Portogallo 10
TZ - Tanzania 10
UZ - Uzbekistan 10
BZ - Belize 9
CI - Costa d'Avorio 9
DK - Danimarca 9
HR - Croazia 9
HU - Ungheria 9
KH - Cambogia 9
NO - Norvegia 9
PA - Panama 9
PR - Porto Rico 9
RS - Serbia 9
SI - Slovenia 9
TH - Thailandia 9
UY - Uruguay 9
AM - Armenia 8
BS - Bahamas 8
CM - Camerun 8
CV - Capo Verde 8
CZ - Repubblica Ceca 8
EG - Egitto 8
ET - Etiopia 8
GA - Gabon 8
HN - Honduras 8
KR - Corea 8
KZ - Kazakistan 8
MG - Madagascar 8
MY - Malesia 8
NG - Nigeria 8
PH - Filippine 8
TJ - Tagikistan 8
TT - Trinidad e Tobago 8
YT - Mayotte 8
BE - Belgio 7
BJ - Benin 7
GF - Guiana Francese 7
LB - Libano 7
LT - Lituania 7
LY - Libia 7
ME - Montenegro 7
ML - Mali 7
SN - Senegal 7
Totale 6.819
Salva come PNG Salva come JPEG
Città #
Fairfield 609
Ashburn 476
Singapore 335
Chandler 326
Hong Kong 266
Woodbridge 251
Cambridge 233
Houston 212
Seattle 198
Ann Arbor 133
Wilmington 132
Beijing 88
Boardman 86
Santa Clara 74
San Diego 60
Munich 59
Princeton 56
Padova 55
Medford 52
Bytom 45
Des Moines 36
Los Angeles 35
Rome 32
Helsinki 31
Milan 31
Roxbury 30
Nanjing 21
New York 21
London 20
São Paulo 19
Vienna 19
Dublin 18
Guangzhou 18
Amsterdam 17
Falkenstein 17
Ho Chi Minh City 15
Verona 15
Hefei 13
Frankfurt am Main 12
Willemstad 12
Brasília 11
Chennai 11
Turku 11
Baku 10
Dallas 10
Amman 9
Boston 9
Buffalo 9
Chicago 9
Kingston 9
Panama City 9
San José 9
Abidjan 8
Baghdad 8
Dushanbe 8
Düsseldorf 8
Fortaleza 8
Lappeenranta 8
Libreville 8
Montevideo 8
Nassau 8
Phnom Penh 8
Rio de Janeiro 8
Tashkent 8
Atlanta 7
Cotonou 7
Council Bluffs 7
Dakar 7
Dar es Salaam 7
Lima 7
Ljubljana 7
Naples 7
Nuremberg 7
Praia 7
Shenyang 7
Addis Ababa 6
Antananarivo 6
Bogotá 6
Castries 6
Conakry 6
Curitiba 6
Dubai 6
Guatemala City 6
Hanoi 6
Jinan 6
Kigali 6
Lusaka 6
Mexico City 6
Montreal 6
Oslo 6
Podgorica 6
San Francisco 6
Tallinn 6
Toronto 6
Washington 6
Auckland 5
Bamako 5
Belize City 5
Brisbane 5
Cagliari 5
Totale 4.612
Salva come PNG Salva come JPEG
Nome #
Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study) 185
Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: A two-year prospective observational study. 172
Serological markers of erosive hand osteoarthritis 167
A recently developed MRI scoring system for hand osteoarthritis: its application in a clinical setting 162
SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients 162
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab 161
Molecular mechanisms of pain in crystal-induced arthritis 154
Erosive hand osteoarthritis: latest findings and outlook 153
Influence of tumor necrosis factor α inhibitors on testicular function and semen in spondyloarthritis patients 145
Lengthening the time intervals between doses of biological agents in psoriatic arthritis patients: A single-center retrospective study 145
Spine and sacroiliac joints on magnetic resonance imaging in patients with early axial spondyloarthritis: Prevalence of lesions and association with clinical and disease activity indices from the italian group of the SPACE study 144
The controversial relationship between osteoarthritis and osteoporosis: an update on hand subtypes 143
Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients 143
Severe Abdominal Pain as a Manifestation of Pseudogout in Pubic Symphysis 142
Biomarkers, imaging and disease activity indices in patients with early axial spondyloarthritis: The Italian arm of the SpondyloArthritis-Caught-Early (SPACE) Study 140
Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis 139
Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment 138
Serological markers in psoriatic arthritis: promising tools 135
Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort 135
Work productivity is associated with disease activity and functional ability in Italian patients with early axial spondyloarthritis: An observational study from the SPACE cohort 125
IL TREAT-TO-TARGET NELLA REAL-LIFE IN PAZIENTI AFFETTI DA ARTRITE PSORIASICA 124
Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis 123
Infection relapse in spondyloarthritis treated with biological drugs: A single-centre study 122
The prevalence of monosodium urate and calcium pyrophosphate crystals in synovial fluid from wrist and finger joints 119
Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study 116
Influence of tumor necrosis factor α inhibitors on testicular function and semen in spondyloarthritis patients 115
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study 114
Bone edema of the whole vertebral body: an unusual case of spondyloarthritis 112
Efficacy and Safety of Ultrasound-Guided Intra-articular Glucocorticoid Injection in Erosive Hand Osteoarthritis 106
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study 105
Do obesity and overweight influence disease activity measures in axial spondyloarthritis? A systematic review and meta-analysis 99
Mediterranean diet in axial spondyloarthritis: an observational study in an Italian monocentric cohort 99
Disease and treatment-related morbidity in young and elderly patients with granulomatosis with polyangiitis and microscopic polyangiitis 97
Influenza vaccine with adjuvant on disease activity in psoriatic arthritis patients under anti-TNF-α therapy 95
An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision 95
Do we believe in non-radiographic axial spondyloarthritis? A debate 94
Relationship between sex and clinical and imaging features of early axial spondyloarthritis: results from a 48 month follow-up (Italian arm of the SPondyloArthritis Caught Early (SPACE) study) 93
Psoriasis and Imaging Progression in early Axial Spondyloarthritis: Results from a 48-month follow-up (Italian arm of SPACE study) 93
Subclinical enthesopathy of the midfoot: could it be a peculiar feature in early psoriatic arthritis? 92
The impact of diet on disease activity in spondyloarthritis: A systematic literature review 90
Validation of the italian version of the educational needs assessment tool in rheumatoid arthritis patients and factors associated with educational needs 90
Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFα, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study 90
The Genetic Contribution to Drug Response in Spondyloarthritis: A Systematic Literature Review 87
Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study 87
Acute joint swelling in psoriatic arthritis: Flare or "psout"-A 10-year-monocentric study on synovial fluid 86
Renal involvement at baseline can predict major renal relapse in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis 85
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement 85
Impact of disease duration and gender on the sensitivity and specificity of 2015 ACR/EULAR classification criteria for gout. Cross-sectional results from an Italian multicentric study on the management of crystal-induced arthritis (ATTACk) 84
Unusual ossification: psoriatic arthritis or not? 83
Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort study 81
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update 81
Acute joint swelling in psoriatic arthritis: Flare or “psout”—A 10-year-monocentric study on synovial fluid 81
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 78
Spine and Sacroiliac Joints Lesions on Magnetic Resonance Imaging in Early Axial-Spondyloarthritis During 24-Months Follow-Up (Italian Arm of SPACE Study) 78
The Risk of overdiagnosis and overtreatment in spondyloarthritis 73
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort 73
Subclinical atherosclerosis evolution during 5 years of anti-TNF-alpha treatment in psoriatic arthritis patients. 70
SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology 68
External validation of the alternative Ankylosing Spondylitis Disease Activity Score in three randomised clinical trials of ixekizumab 64
Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study 63
Search for Galactic axions with a high- Q dielectric cavity 63
Treat-to-target in real-life psoriatic arthritis patients: achieving minimal disease activity with bDMARDs/tsDMARDs and potential barriers 63
Identification in synovial fluid of a new potential pathogenic player in arthropathies 59
Clinical vignette: a rare presentation of a first gout flare 54
Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis 54
Answer to Ben Nessib et al. Joint Bone Spine 2023;90:105539 52
Le malattie autoimmuni 46
Comment on: Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable: reply 39
Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable 38
Which disease activity outcome measure discriminates best in axial spondyloarthritis? A systematic literature review and meta-analysis 36
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis 30
null 3
Totale 7.217
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.642
article - articoli 28.227
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 154
Totale 57.023
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021659 0 0 41 36 8 39 15 54 65 85 73 243
2021/2022837 32 106 42 63 17 77 55 82 22 53 58 230
2022/2023587 143 72 17 65 80 52 3 37 55 13 17 33
2023/2024527 10 47 54 60 33 62 40 53 37 28 43 60
2024/20251.845 6 155 73 89 205 64 98 213 114 102 285 441
2025/20261.630 415 498 717 0 0 0 0 0 0 0 0 0
Totale 7.217